Showing 61–72 of 116 results
-
-
Ocrevus
FreeTrade Name Ocrevus Active Ingredient Ocrelizumab Power 300 mg Type / form Injection Status NA Manufacturer Roche -
-
Ondexxya
FreeTrade Name Ondexxya Active Ingredient Andexanet Alfa Power 200mg Type / form Injection Status NA Manufacturer Astra Zeneca -
Onivyde
FreeTrade Name Onivyde Active Ingredient Irinotecan Power 43 mg Type / form Injection Status NA Manufacturer Incyte -
-
-
Opzelura
FreeTrade Name Opzelura Active Ingredient Ruxolitinib Power 1.5% Type / form Cream Status NA Manufacturer Incyte -
Ozempic
FreeTrade Name Ozempic Active Ingredient Semaglutide Power 0.25mg,0.5mg, 0.75mg,1 mg Type / form Injection Status NA Manufacturer Novonordisk -
Padcev
FreePadcev (enfortumab vedotin-ejfv) is a Nectin-4-directed antibody and microtubule inhibitor conjugate used:
as a single agent for the treatment of adults with locally advanced or metastatic urothelial cancer who have previously been treated with programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and platinum-containing chemotherapy, or are ineligible for cisplatin-containing chemotherapy and have previously treated with one or more prior lines of therapy.
along with medicine pembrolizumab to treat adults with locally advanced or metastatic urothelial cancer (mUC) who are not eligible for cisplatin-containing chemotherapy. -
Perjeta
FreeTrade Name Perjeta Active Ingredient Pertuzumab Power 420 mg Type / form Injection Status NA Manufacturer Roche -
Phesgo
FreeTrade Name Phesgo Active Ingredient Pertuzumab /Trastuzumab /Hyaluronidase Power 600mg, 1200mg Type / form Injection Status NA Manufacturer Roche
